RoukenBio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

RoukenBio General Information

Description

Provider of preclinical immunology and bioassay research services intended for the biotechnology and pharmaceutical sectors. The company offers cell line engineering, safety assessments, and efficacy studies, enabling biotherapeutic innovators to develop advanced therapeutics through proprietary inducible cell line platforms and specialized cellular models.

Contact Information

Website
www.rouken.bio
Formerly Known As
Antibody Analytics
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Rouken Discovery Centre
  • Braidhurst Industrial Estate
  • Motherwell ML1 3ST
  • Scotland, United Kingdom
+44 01698
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Rouken Discovery Centre
  • Braidhurst Industrial Estate
  • Motherwell ML1 3ST
  • Scotland, United Kingdom
+44 01698

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RoukenBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RoukenBio‘s full profile, request access.

Request a free trial

RoukenBio Patents

RoukenBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023345968-A1 Integration and selection system Pending 21-Sep-2022
EP-4590834-A1 Integration and selection system Pending 21-Sep-2022
US-20260092272-A1 Integration and selection system Pending 21-Sep-2022
WO-2024062248-A1 Integration and selection system Inactive 21-Sep-2022
AU-2023266191-A1 Chemically induced proximity systems Pending 06-May-2022 G01N33/505
To view RoukenBio’s complete patent history, request access »

RoukenBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RoukenBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RoukenBio‘s full profile, request access.

Request a free trial

RoukenBio FAQs

  • When was RoukenBio founded?

    RoukenBio was founded in 2015.

  • Where is RoukenBio headquartered?

    RoukenBio is headquartered in Motherwell, United Kingdom.

  • What is the size of RoukenBio?

    RoukenBio has 100 total employees.

  • What industry is RoukenBio in?

    RoukenBio’s primary industry is Drug Discovery.

  • Is RoukenBio a private or public company?

    RoukenBio is a Private company.

  • What is RoukenBio’s current revenue?

    The current revenue for RoukenBio is .

  • How much funding has RoukenBio raised over time?

    RoukenBio has raised $624K.

  • Who are RoukenBio’s investors?

    NorthEdge Capital, Innovate UK, and UKSE (Sheffield) have invested in RoukenBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process